spironolactone has been researched along with cyclic gmp in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donker, AJ; Hackeng, WH; Meuwissen, SG; van Vliet, AA | 1 |
| Currie, MG; Lanier-Smith, KL | 1 |
| Boedeker, EC; Charney, AN; Decker, RA; Donowitz, M; Marnane, WG; Tai, YH | 1 |
| Alonso, MJ; Alvarez, Y; Balfagón, G; Cachofeiro, V; Lahera, V; Márquez-Rodas, I; Salaices, M | 1 |
| Burnett, JC; Chen, HH; Frantz, RP; Hodge, DO; Karon, BL; Miller, WL; Owan, TE; Redfield, MM; Rodeheffer, RJ | 1 |
| Amâncio, Gde C; de Assis, LV; Faria, Gde O; Hermidorff, MM; Isoldi, MC | 1 |
| Adler, GK; Khalil, RA; Opsasnick, LA; Pojoga, LH; Reslan, OM; Siddiqui, WT; Williams, GH; Yao, TM | 1 |
1 trial(s) available for spironolactone and cyclic gmp
| Article | Year |
|---|---|
The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction.
Topics: Aged; Algorithms; Blood Urea Nitrogen; Creatinine; Cyclic GMP; Diuresis; Drug Administration Schedule; Drug Therapy, Combination; Endothelium; Female; Heart Failure; Humans; Kidney; Male; Mineralocorticoid Receptor Antagonists; Natriuretic Agents; Natriuretic Peptide, Brain; Renal Insufficiency, Chronic; Spironolactone; Stroke Volume; Time Factors | 2008 |
6 other study(ies) available for spironolactone and cyclic gmp
| Article | Year |
|---|---|
Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Captopril; Creatinine; Cyclic GMP; Diuresis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Humans; Kidney; Liver; Liver Cirrhosis; Male; Middle Aged; Renal Dialysis; Renin; Sodium; Spironolactone | 1992 |
Glucocorticoid regulation of atrial natriuretic peptide receptors on cultured endothelial cells.
Topics: Animals; Atrial Natriuretic Factor; Autoradiography; Binding, Competitive; Cells, Cultured; Cross-Linking Reagents; Cyclic GMP; Dexamethasone; Endothelium, Vascular; Glucocorticoids; Mifepristone; Peptide Fragments; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Spironolactone | 1991 |
Methylprednisolone stimulation of guanylate cyclase activity in rat small intestinal mucosa: possible role in electrolyte transport.
Topics: Animals; Biological Transport; Colon; Cyclic AMP; Cyclic GMP; Desoxycorticosterone; Electrolytes; Guanylate Cyclase; Ileum; Intestinal Mucosa; Male; Methylprednisolone; Rats; Spironolactone | 1981 |
Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide.
Topics: Adenine; Adenosine Triphosphate; Aldosterone; Animals; Anti-Arrhythmia Agents; Calcitonin Gene-Related Peptide; Capsaicin; Cyclic GMP; Electric Stimulation; Enzyme Inhibitors; Glyburide; Hypertension; Male; Mesenteric Arteries; Mineralocorticoid Receptor Antagonists; Neurons; NG-Nitroarginine Methyl Ester; Norepinephrine; Potassium Channels; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Glucocorticoid; Spironolactone; Vasoconstriction; Vasomotor System | 2004 |
Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?
Topics: Aldosterone; Animals; Calcium; Cell Proliferation; Cyclic AMP; Cyclic GMP; Eplerenone; Female; Male; MAP Kinase Signaling System; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction; Spironolactone | 2015 |
Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiovascular System; Caveolin 1; Cyclic GMP; Eplerenone; Heart Injuries; Male; Mice; Mineralocorticoid Receptor Antagonists; Models, Molecular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nucleic Acid Conformation; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction; Spironolactone; Vasoconstriction; Vasodilation | 2015 |